Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$BIIB Q2 '26 Earnings Results & Recap • Reported GAAP EPS of $0.66 down -84.76% YoY • Reported revenue of $2.74B up 3.42% YoY • Biogen expects full year 2026 Non-GAAP diluted EPS of $12.00 to $13.00, while total revenue is projected to increase by a mid-single digit percentage compared to 2025 for Biogen.

Price since post

Full Details

Advertisement|Remove ads.